Dr Peter Prinsley, the MP for Bury St Edmunds and Stowmarket, held a debate in Westminster on the welfare of doctors and the overall state of the NHS, which is a ‘matter of personal importance’ for ...
Boing Boing on MSN1d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...
Kratom is known for its stimulant and opioid-like effects and is derived from the leaves of a tree in the coffee family, the Southeast Asian tree Mitragyna speciosa. This differs from another natural ...
These findings build on growing evidence that carefully supervised psilocybin therapy can be both safe and effective for ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback